Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Please just this one time let it go
The FDA rallied behind us at the Adcom. Why would you send this
Please let the company do its job Please
All of this anguish would not be worth $55/share. This seems like a really low number
Liam Nielsen with his unique set of skills may be able to find out??????
There should be no outreach of any kind. If it goes public on any forum that anyone is reaching out to old members someone with nefarious intentions can make statements even if they are false that we are also trying to reach current members
All they have to do is present any questions on the integrity of the process, raise any concerns, cast any doubt and we will pay the price.
There is absolutely nothing to be gained by this and everything to lose.
No directed to you JL, this is directed to anyone who thinks reaching out to anyone associated with the panel past or present is high risk, zero reward proposition
All someone with bad intentions needs to do is to see this on our message board and everything can go down hill very quickly.
If you believe in v and management just let the process run its course
My person opinion is that we should be praying about this, trust management and the science and stop badgering people for insight that will have no bearing or weight on our current situation
Jmo not condemning or pointing fingers
You’re right it is not illegal but with all that has transpired with this stock, with all of the fake narratives I.e. pyrr, Marc why give anyone any ammo to potentially use against us.
What do you think Mac would try to do with this if they found out we were contacting old ad com members.
He would falsely post how uncertain we, create more fund and background noise and so on. He has done more damage with less wouldn’t you agree.
Besides what real worth is to be gained by finding out what they would do now|
He has already contacted fda about this meddling. These inquiries can only hurt the outcome
Will do. Thank you for the information
Have you heard of this disease. I see that it is progressive and as I said has some of connection with system/vascular information. I know JL has said that inflammation is a problem that v can address. I am hoping v can help her with both the depression and the vascular inflammation.
Thank you for your response and concern
Amrn board members
I know many thought that I would not be heard from again but I wanted to address two issues within this post.
First I have never had issue with the clinical side of amrn but rather the internal market forces. I believe that V has unbounded clinically benefits and brings me to the true reason for this post.
I just learned that a long time, dear friend has been diagnosed with White Matter Tissue Disease. I do not have much background on the disease state, and was hoping there is someone on the board that has experience with it and most importantly whether Vascepa might help. There is no cure and it does in part have its’ genesis with long term diabetes, hypertension and vascular inflammation. It ultimately effects movement and memory as the disease wears away tissue from the largest area of the brain and then impacts nerves, myelin and motor and memory function.
I would like to approach her physician about V. Can anyone provide resources or direction.
Thank you
My friend is already becoming depressed with the long term prognosis and I am afraid that her physician will not be open to Vascepa as a means of treatment.
Sincerely
Sorry did know I could just voice what I thought might be happening based upon past events
Like the hit pieces, like jl halting the momentum with a previous offering, like the fact that people’s opinion I respect are hedging, like the mineral oil issue. If those are not enough for you no problem, however it is enough for me
Whether you have a clear conscience or not is not up to me. It should based on your heart and the reflection in the mirror
Again. Not every long. Just because you did does not mean that all did
You make too many assumptions particularly your remark about a quick buck
Demeaning and uncalled for
I got in high simply because I did not learn of the stock until late
I simply do not see the same future you do and am moving on which is my choice
You’re welcome
Just look to past history with this stock
Either outside shorts take it down with their actions of mgt with its ill timed moves (ref latest dilution) kill it internally.
Gs sacks just got paid at our expense
Jeffries got paid
Shorts getting paid
Mgt getting paid
Did I miss anyone ... no. Only retail holders on the outside looking in have missed the money train
What is most appalling is all of these shenanigans going on at the expense of these groups being so greedy and patients are the ones really taking it in the neck
Jt,fda institutions are sucking the life out of this day by day
Good for you
Because I wanted to
Far too many unknowns for what is supposed to be potential blockbuster drug.
I will be selling my shares tomorrow.
Something is up and it does not seem very good
I am particularly distressed by JL and his change of heart but I think he is right. This may be about to go side ways for a number of reasons
1 internal Amarin greed
2 fda integrity issues
3 a sudden management/manufacturing/supply problem
4 less than stellar icer findings
Jmo but this stock has too many uncertainties for me
I am out
Can I accomplish the same by a stop loss
With all of the difficulties associated with this stock and some of the actions of the management did you really in your heart of hearts that the dilution would be a good thing
Just a heads up ICER is probably going to be the next undoing of this stock
Forgive my ingnorance but what is the shoe
Talk about death by a million cuts
They more than likely are not hiring reps because no matter how many you have, there is limited access to physicians and their staff and this limiting access grow more pronounced each day
You could have 5000 reps, no 10000 and it will not significantly impact acces, and in fact may hinder it
To Gia this needs to be sold to a bp that already has established relationships and access to these offices predicated on the products they are already promoting to these providers.
You have no idea how limited both physical and concentrated mental access to physicians is unless you have already established value added goodwill with them that has been established over time and over many products
It is probably best that you stop thinking in terms of numbers and focus more on access or in a broader sense b/o to a bp that has reps with established products and relationships where they can piggy back v into their conversations
Jmo
Which May be why there have been no offers. The risk is too great
Great just what the street needs to hear. This along with ad com/no adcom/patent issues/ doubt about snda is not reassuring. This will definitely hinder pps and buyer interest
And another potential buyer is gone I think
Gia looks more difficult with each day
So I guess they would longer have an interest in acquiring us
Yes
Thank you very much. Still trying to grasp certain concepts and information
Thanks again
Sorry I do not understand your post
I would really love $75 pps
I do not understand why every bo offer on this board seems low to me. I keep seeing ranges from $40 - 60. This seems low to me. Am I missing something. I thought the bo pps would be closer to $80. Or a pps of at least $50 and cvr
Just asking but if a bo occurs is $0 - 85 too high
Any flexibility for cash and CVR?
2021?
Can the expansion of the label come before sept 30th
Not meant for anyone in particular but it must be obvious that there will always be something holding this stock from getting to patients and the pps going sideways until it is sold.
There is always a new hurdle and then someone saying ‘“just 6 more months” or in “2023” or some other far off nebulous date.
I have seen a definitive difference especially at the difficult crown of my hair
The difference is real
Not sure I am on the right track with question, but how can Amarin receive expanded label if they are already expressing supply issues. Isn’t the ability to show this capability key to approval of expanded label
Just a question for clarification
If V get FDA priority review, what would be the earliest day for actual expansion of label.
Sorry my response was not directed to you. After working for bid Pharma firms for close to 25 years I know how ruthless they can be. They want what they want when they want it and on their terms and will stop at nothing to get it
I think in general that this board is underestimating the hurdles of Gia and also of what bp will pay for v
You guys keep talking about 2020 as if it is a given. If JT does not sell and sell soon there will be nothing to sell
How many hits do you have to experience before you come to the realization that this drug is not going to be allowed to move until it is out of Amarin’s hands.
Reduce-it. Should have been a home run. Strike 1
Ada /sock should have been a home run. Strike 2
New managed care wins should have been a home run Strike 3
Expanded sales force. Should have been a home run. Strike 4
Quick Canadian adoption should have been a home run. Strike 5
Priority review should be a home run. Strike???
So aren’t these guys on Amarin “payroll”